Приказ основних података о документу

dc.creatorVekić, Jelena
dc.creatorZeljković, Aleksandra
dc.creatorBogavac-Stanojević, Nataša
dc.creatorJelić-Ivanović, Zorana
dc.creatorSpasojević-Kalimanovska, Vesna
dc.creatorSimić-Ogrizović, Sanja
dc.creatorDopsaj, Violeta
dc.creatorSpasić, Slavica
dc.date.accessioned2019-09-02T11:25:41Z
dc.date.available2019-09-02T11:25:41Z
dc.date.issued2011
dc.identifier.issn0009-9120
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/1569
dc.description.abstractObjective: Dyslipidemia is commonly seen in patients with end-stage renal disease (ESRD). This prospective study investigates whether small-sized high-density lipoprotein (HDL) particles alone or in combination with high sensitivity C-reactive protein (hsCRP) are independent determinants of ESRD mortality. Design and methods: We performed 36 months follow-up study in 122 haemodialysis (HD) patients. HDL size and subclass distribution were determined by gradient gel electrophoresis. Baseline characteristics of the patients were evaluated for the prediction of mortality. Results: Cox regressions analysis showed that patients with small-sized HDL particles had 2.8-fold higher risk of lethal outcome (P lt 0.05). Concomitant presence of small-sized HDL particles and increased hsCRP concentration were significantly associated with reduced survival rate (HR = 3.907; P lt 0.05). Observed relationships persisted after adjustment for serum lipid and lipoprotein concentrations. Conclusions: Our results indicate that small-sized HDL particles alone and combined with elevated hsCRP concentrations are independent predictors of reduced survival in HD patients.en
dc.publisherPergamon-Elsevier Science Ltd, Oxford
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS//
dc.rightsrestrictedAccess
dc.sourceClinical Biochemistry
dc.subjectRenal diseaseen
dc.subjectHaemodialysisen
dc.subjectHDL sizeen
dc.subjectInflammationen
dc.subjectC-reactive proteinen
dc.titleCox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particlesen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractСпасић, Славица; Јелић-Ивановић, Зорана; Спасојевић-Калимановска, Весна; Зељковић, Aлександра; Допсај, Виолета; Симић-Огризовић, Сања; Векић, Јелена; Богавац-Станојевић, Наташа;
dc.citation.volume44
dc.citation.issue8-9
dc.citation.spage635
dc.citation.epage641
dc.citation.other44(8-9): 635-641
dc.citation.rankM22
dc.identifier.wos000291081400012
dc.identifier.doi10.1016/j.clinbiochem.2011.02.002
dc.identifier.pmid21320480
dc.identifier.scopus2-s2.0-79955794222
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу